Cardiovascular disease remains the number one cause or mortally in the western world. Heart failure is the most rapidly growing cardiovascular disease (Hobbs, 2004; Levy, et al., 2002). Heart failure, by definition, is progressive deteriorating function of the heart due to progressive cardiac myocytes loss. Though after decades of endeavor of searching the pathophysiology and treatments for heart failure, it remains highly lethal. Therefore, it is vital to find novel therapies to help treat such chronic disease. Replace the lost cardiomyocyte with new ones could restore cardiac function and reduce mortality. The purpose of this study is to investigate on how TTCCs (T-type calcium channels) affect cardiomyocyte proliferation. In mice after birth, the major TTCC expressed in the heart is Cav3.1/α1G, and therefore we used Cav3.1/α1G transgenic (TG), knockout (-/-) and wild type mice respectively to define the role of TTCC in cardiomyocyte proliferation. In neonatal mouse ventricular myocyte (NMVMs) right after birth, there is almost no TTCC after birth in α1G-/- NMVMs, whereas there are around 35% NMVMs in wild type (WT) show TTCC. On day 7 after birth, there are no T-type calcium currents in both α1G-/- NMVMs and WT NMVMs. Using BrdU, a DNA synthesis marker, we identified plenty of BrdU positive cardiomyocyte during the first seven days after birth. Cardiomyocyte is special due to its double nucleation property. Our cell cycle studies showed that there is significant difference in cell cycle distribution between α1G-/- and WT NMVMs on day seven after birth. Significantly more NMVMs are arrested in G1 phase in α1G-/-, compared to WT NMVMs. Even until 2 month old, there are still significantly more mono-nucleated cardiomyocyte in α1G-/- than in WT. In conclusion, all these evidence showed that blocking T-type calcium channel could partially prevent binucleation from happening and stop cardiomyocytes withdrawal from cell cycle. Mononucleated cardiomyocyte is still able to proliferate. Hence, mononucleated cardiomyocytes in adult still have potential to proliferation because these cardiomyoctes are arrested in their cell-cycle before their terminal differentiation, which could offer a novel approach for cardiac repair. / Physiology

Yes / Ion channels represent a large and growing family of target proteins regulated by gasotransmitters such as nitric oxide, carbon monoxide and, as described more recently, hydrogen sulfide. Indeed, many of the biological actions of these gases can be accounted for by their ability to modulate ion channel activity. Here, we report recent evidence that H2S is a modulator of low voltage-activated T-type Ca2+ channels, and discriminates between the different subtypes of T-type Ca2+ channel in that it selectively modulates Cav3.2, whilst Cav3.1 and Cav3.3 are unaffected. At high concentrations, H2S augments Cav3.2 currents, an observation which has led to the suggestion that H2S exerts its pro-nociceptive effects via this channel, since Cav3.2 plays a central role in sensory nerve excitability. However, at more physiological concentrations, H2S is seen to inhibit Cav3.2. This inhibitory action requires the presence of the redox-sensitive, extracellular region of the channel which is responsible for tonic metal ion binding and which particularly distinguishes this channel isoform from Cav3.1 and 3.3. Further studies indicate that H2S may act in a novel manner to alter channel activity by potentiating the zinc sensitivity/affinity of this binding site. This review discusses the different reports of H2S modulation of T-type Ca2+ channels, and how such varying effects may impact on nociception given the role of this channel in sensory activity. This subject remains controversial, and future studies are required before the impact of T-type Ca2+ channel modulation by H2S might be exploited as a novel approach to pain management. / This work was supported by grants from the British Heart Foundation, the Medical Research Council, and the Hebei Medical University

No / T-type Ca2+ channels (Cav3.1, 3.2 and 3.3) strongly influence proliferation of various cell types, including vascular smooth muscle cells (VSMCs) and certain cancers. We have recently shown that the gasotransmitter carbon monoxide (CO) inhibits T-type Ca2+ channels and, in so doing, attenuates proliferation of VSMC. We have also shown that the T-type Ca2+ channel Cav3.2 is selectively inhibited by hydrogen sulfide (H2S) whilst the other channel isoforms (Cav3.1 and Cav3.3) are unaffected. Here, we explored whether inhibition of Cav3.2 by H2S could account for the anti-proliferative effects of this gasotransmitter. H2S suppressed proliferation in HEK293 cells expressing Cav3.2, as predicted by our previous observations. However, H2S was similarly effective in suppressing proliferation in wild type (non-transfected) HEK293 cells and those expressing the H2S insensitive channel, Cav3.1. Further studies demonstrated that T-type Ca2+ channels in the smooth muscle cell line A7r5 and in human coronary VSMCs strongly influenced proliferation. In both cell types, H2S caused a concentration-dependent inhibition of proliferation, yet by far the dominant T-type Ca2+ channel isoform was the H2S-insensitive channel, Cav3.1. Our data indicate that inhibition of T-type Ca2+ channel-mediated proliferation by H2S is independent of the channels’ sensitivity to H2S. / This work was supported by the British Heart Foundation (PG/11/84/29146).

No / T-type Ca2+ channels are a distinct family of low voltage-activated Ca2+ channels which serve many roles in different tissues. Several studies have implicated them, for example, in the adaptive responses to chronic hypoxia in the cardiovascular and endocrine systems. Hydrogen sulfide (H2S) was more recently discovered as an important signalling molecule involved in many functions, including O2 sensing. Since ion channels are emerging as an important family of target proteins for modulation by H2S, and both T-type Ca2+ channels and H2S are involved in cellular responses to hypoxia, we have investigated whether recombinant and native T-type Ca2+ channels are a target for modulation by H2S. Using patch-clamp electrophysiology, we demonstrate that the H2S donor, NaHS, selectively inhibits Cav3.2 T-type Ca2+ channels heterologously expressed in HEK293 cells, whilst Cav3.1 and Cav3.3 channels were unaffected. Sensitivity of Cav3.2 channels to H2S required the presence of the redox-sensitive extracellular residue H191, which is also required for tonic binding of Zn2+ to this channel. Chelation of Zn2+ using TPEN prevented channel inhibition by H2S. H2S also selectively inhibited native T-type channels (primarily Cav3.2) in sensory dorsal root ganglion neurons. Our data demonstrate a novel target for H2S regulation, the T-type Ca2+ channel Cav3.2. Results have important implications for the proposed pro-nociceptive effects of this gasotransmitter. Implications for the control of cellular responses to hypoxia await further study.

No / T-type Ca2+ channels regulate proliferation in a number of tissue types, including vascular smooth muscle and various cancers. In such tissues, up-regulation of the inducible enzyme heme oxygenase-1 (HO-1) is often observed, and hypoxia is a key factor in its induction. HO-1 degrades heme to generate carbon monoxide (CO) along with Fe2+ and biliverdin. Since CO is increasingly recognized as a regulator of ion channels (Peers et al. 2015), we have explored the possibility that it may regulate proliferation via modulation of T-type Ca2+ channels. Whole-cell patch-clamp recordings revealed that CO (applied as the dissolved gas or via CORM donors) inhibited all 3 isoforms of T-type Ca2+ channels (Cav3.1-3.3) when expressed in HEK293 cells with similar IC50 values, and induction of HO-1 expression also suppressed T-type currents (Boycott et al. 2013). CO/HO-1 induction also suppressed the elevated basal [Ca2+ ]i in cells expressing these channels and reduced their proliferative rate to levels seen in non-transfected control cells (Duckles et al. 2015). Proliferation of vascular smooth muscle cells (both A7r5 and human saphenous vein cells) was also suppressed either by T-type Ca2+ channel inhibitors (mibefradil and NNC 55-0396), HO-1 induction or application of CO. Effects of these blockers and CO were non additive. Although L-type Ca2+ channels were also sensitive to CO (Scragg et al. 2008), they did not influence proliferation. Our data suggest that HO-1 acts to control proliferation via CO modulation of T-type Ca2+ channels.

The L-type calcium channel (LTCC) provides trigger Ca2+ for sarcoplasmic reticulum Ca2+-release and LTCC function is influenced by interacting proteins including the LTCC Distal Carboxyl-terminus (DCT) and calmodulin. DCT is proteolytically cleaved, and re-associates with the LTCC complex to regulate calcium channel function. DCT reduces LTCC barium current (IBa,L) in reconstituted channel complexes, yet the contribution of DCT to ICa,L in cardiomyocyte systems is unexplored. This study tests the hypothesis that DCT attenuates cardiomyocyte ICa,L. We measured LTCC current and Ca2+ transients with DCT co-expressed in murine cardiomyocytes. We also heterologously co-expressed DCT and CaV1.2 constructs with truncations corresponding to the predicted proteolytic cleavage site, CaV1.2Δ1801, and a shorter deletion corresponding to well-studied construct, CaV1.2Δ1733. DCT inhibited IBa,L in cardiomyocytes, and in HEK 293 cells expressing CaV1.2Δ1801 and CaV1.2Δ1733. Ca2+-CaM relieved DCT block in cardiomyocytes and HEK cells. The selective block of IBa,L combined with Ca2+-CaM effects suggested that DCT-mediated blockade may be relieved under conditions of elevated Ca2+. We therefore tested the hypothesis that DCT block is dynamic, increasing under relatively low Ca2+, and show that DCT reduced diastolic Ca2+ at low stimulation frequencies but spared high frequency Ca2+-entry. DCT reduction of diastolic Ca2+ and relief of block at high pacing frequencies, and under conditions of supraphysiological bath Ca2+ suggests that a physiological function of DCT is to increase the dynamic range of Ca2+ transients in response to elevated pacing frequencies. Our data motivates the new hypothesis that DCT is a native reverse use-dependent inhibitor of LTCC current.

Abstract The dihydropyridine receptor (DHPR) in the skeletal muscle plasma membrane functions as a voltage sensor for excitation-contraction coupling. In the present work the expression and special features of DHPR were studied under various conditions. In order to localize and visualize the DHPRs, a method using fluorophore-conjugated dihydropyridine molecules as a probe was developed. In addition, different laboratory assays and electrophysiological measurements were used to study the expression of the myofibrillar proteins, force production of the muscle and conduction velocity of the plasma membrane. During the postnatal development of mouse skeletal muscle the density of DHPR increased. By the time of DHPR appearance, the expression of sodium channels had started and the typical assembly of basic structural components and membrane compartments was clearly detectable. According to the histochemical analysis, the DHPR was selectively expressed in type IIA muscle fibres of mouse. In addition to the fibre type specificity, the uneven distribution of DHPRs was also seen at the muscle level. The attenuation of the contraction force after addition of DHPR blocker was largest in muscles with a high percentage of type IIA fibres. In fish muscles, the distribution of DHPR was homogenous and the density between different fibre types was quite similar. In gastrocnemius muscle of mouse, the density and mRNA expression of DHPR increased significantly by 21.5 and 66.8%, respectively, after a 15-week aerobic exercise programme. The increase correlated significantly with the raise in % myosin heavy chain IIa isoform. In thigh and heart muscles, no significant changes were observed. In fish, the environmental change following hatchery release and downstream migration of 46.5 km induced an increase in the DHPR density in swimming muscles. Furthermore, a transition of phenotypic profile from fast-to-slow fibres was observed. Taken together, the present data provide evidence for the fact that the expression of DHPR increases during postnatal development. Moreover, the expression correlates with a specific fibre-type metabolism, thus having an impact on the overall contractile properties of the muscle. This is further manifested as an increase in the DHPR density after endurance training in mammalian as well as in fish muscle. In addition, a strong correlation exists between the level of muscle activity and the density of DHPR. / Tiivistelmä Poikkijuovaisen lihaksen solukalvolla esiintyvä dihydropyridiini (DHP) reseptori toimii jännitesensorina lihaksen ärsytys-supistus kytkennässä. Tässä työssä tutkittiin DHP reseptorin erityispiirteitä sekä erilaisten fysiologisten tekijöiden vaikutusta reseptorin ilmenemiseen. DHP reseptorien visualisointiin kehitettiin histologinen värjäysmenetelmä, jossa merkkiaineena toimi fluorofori-konjugoitu DHP molekyyli. Lisäksi työssä tutkittiin lihaksen proteiinien ekspressiota, lihaksen voimantuottoa sekä solukalvon johtonopeutta erilaisten määritysmenetelmien ja elektrofysiologisten mittausmenetelmien avulla. Tulokset osoittivat, että yksilönkehityksen aikana DHP reseptorien tiheys kasvoi hiiren poikkijuovaisessa lihaksessa. DHP reseptorien ekspression alkaessa natriumkanavat olivat jo ilmaantuneet solukalvolle ja lihassolun rakenne oli pitkälle erilaistunut. Histokemiallisten määritysten perusteella DHP reseptorin ekspressio oli selektiivistä. Reseptoreita esiintyi runsaimmin tyypin IIA soluissa. Reseptoriproteiinin solutyyppispesifisyys oli huomattavissa myös lihastasolla. Tulosten mukaan proteiinin salpaaja alensi lihaksen supistumisvoimaa erityisesti niissä hiiren lihaksissa, joiden solutyyppikoostumuksessa tyypillä IIA on suuri prosentuaalinen osuus. Kalan lihaksissa DHP reseptorit olivat homogeenisesti jakautuneet. Lisäksi reseptoritiheys oli samankaltainen eri solutyyppien välillä. 15 viikon aerobinen harjoittelu lisäsi sekä DHP reseptorin proteiini- että mRNA- ekspressiota tilastollisesti merkitsevästi (21,5 ja 66,8 %) hiiren kantalihaksessa. Ekspression kasvu korreloi merkitsevästi samanaikaisesti tapahtuneen myosiini isomuoto IIa määrän kasvun kanssa. Reisi- ja sydänlihaksessa merkittäviä muutoksia ei havaittu. Kalan uintilihaksissa DHP reseptorien tiheys kasvoi vapauttamisen jälkeisen ympäristön muutoksen ja 46,5 km pituisen vaelluksen jälkeen. Lisäksi lihasten solutyyppikoostumuksessa tapahtui muutos kohti hitaasti supistuvia solutyyppejä. Yhteenvetona voidaan todeta, että saatujen tulosten perusteella DHP reseptorien ekspressio kasvaa syntymän jälkeen hiiren poikkijuovaisessa lihaksessa. Solujen erilaistuessa ekspressio korreloi solutyyppimetabolian kanssa vaikuttaen edelleen lihaksen supistumisominaisuuksiin. Tästä johtuen myös kestävyysharjoittelun seurauksena DHP reseptorien määrä kasvaa sekä nisäkkään että kalan lihaksissa. Erityisesti lihaksen aktiivisuudella on merkitystä DHP reseptorin ekspressioon.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20080号 / 医博第4173号 / 新制||医||1018(附属図書館) / 33196 / 京都大学大学院医学研究科医学専攻 / (主査)教授 長船 健二, 教授 川口 義弥, 教授 小川 修 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Le traitement et la gestion de la douleur sont depuis toujours une priorité pour le corps médical. Malgré leur importance pour la qualité de vie, les analgésiques couramment utilisés possèdent un ratio bénéfice/risque faible. La recherche de nouveaux concepts thérapeutiques pour lutter contre la douleur est donc une priorité. Afin de répondre à ce besoin, il faut d'abord comprendre les mécanismes de la perception de la douleur ainsi que, plus globalement, ceux permettant de percevoir son environnement. Dans ce contexte, de nombreuses études ont mis en évidence l'implication du canal calcique à bas seuil Cav3.2 dans les voies de la transmission de l'information douloureuse. Il représente donc une cible de choix pour le traitement de la douleur mais l'identité des neurones exprimant ces canaux ainsi que la fonction de Cav3.2 dans la physiologie des neurones sensoriels étaient jusqu'à présent inconnues. Au cours de cette thèse nous avons dans un premier temps décrit un nouvel inhibiteur des canaux calciques à bas seuil : le TTA-A2. Nous avons ainsi démontré que le TTA-A2 est un inhibiteur spécifique des canaux Cav3.1, Cav3.2, et Cav3.3. Il permet de diminuer l'excitabilité des neurones sensoriels exprimant Cav3.2, ce qui provoque une analgésie sur des animaux sains et pathologiques. Dans un deuxième temps nous nous sommes servis de ce nouvel outil en parallèle d'un nouveau modèle murin possédant une étiquette fluorescente (Knock in GFP) sur le canal Cav3.2 pour explorer la localisation et la fonction de Cav3.2 dans les neurones sensoriels. Nous avons ainsi découvert que Cav3.2 est exprimé dans des mécanorécepteurs à bas seuil impliqués dans la perception des stimuli mécaniques et thermiques nocifs ou non-nocifs. Le canal en lui-même se trouve aux endroits clés de la genèse et de la propagation du message nerveux périphérique, et module le seuil et la vitesse de conduction des potentiels d'action. Replacé dans le contexte de la bibliographie, l'ensemble de nos résultats montre que Cav3.2 permet de donner la modalité à bas seuil aux neurones l'exprimant. / Pain management and treatment have always been a priority for life quality. Despite this fact, analgesics commonly used present a bad benefice/risk ratio. Discovery of new therapeutic concepts to fight pain is highly required. To complete this task, we first need to better understand pain perception mechanisms, and more globally, mechanisms involved in the perception of our environment. In this context, numerous studies have shown that low threshold calcium channels Cav3.2 are involved in pain information transmission. Thus, it represents a good target for the treatment of pain. However, neuronal identity of Cav3.2-expressing sensory neurons and Cav3.2 functions in neuronal physiology are unknown. During this PhD we first described a new low voltage activated channel antagonist named TTA-A2. We demonstrated that TTA-A2 is a powerful nanomolar specific agonist of Cav3.1, Cav3.2 and Cav3.3. This molecule is able to reduce excitability in sensory neurons expressing Cav3.2, and is able to generate a strong analgesic effect on naive and pathologic animals. In the other part of this PhD, we used this new tool combined to a new transgenic mouse that expressed Cav3.2 tagged with a fluorescent protein (Knock-in GFP). With these new tools we discovered that Cav3.2 is expressed in low threshold mechanoreceptors involved in detection of painful and non painful mechanical and thermal stimuli. Cav3.2 itself is expressed at key localisations that allow action potential generation and propagation, and modulate threshold and speed conduction of action potential. Taken together, these results show that Cav3.2 gives the “low threshold” modality to neurons.

Modelos matemáticos de motoneurônios têm sido desenvolvidos para auxiliar na compreensão dos fenômenos que envolvem o sistema neuromuscular. Entretanto, a maioria dos modelos já desenvolvidos baseou-se na premissa de que a árvore dendrítica tem um comportamento passivo, o que ocorre em animais anestesiados, mas pode não ocorrer durante o comportamento motor normal de um animal intacto. Experimentos com animais descerebrados, em que as vias monoaminérgicas encontravam-se ativas, mostraram que os motoneurônios podem apresentar comportamentos mais complexos decorrentes da presença de condutâncias iônicas voltagem-dependentes que se situam nos dendritos e são responsáveis pela gênese de uma corrente de entrada persistente. Nesse sentido, um primeiro objetivo deste trabalho foi o de desenvolver novos modelos matemáticos de motoneurônios de diferentes tipos (i.e. dos tipos S, FR e FF), computacionalmente eficientes e contendo em seus compartimentos dendríticos uma condutância de cálcio do tipo L, de forma que os fenômenos de biestabilidade, potencial platô e amplificação da corrente sináptica efetiva possam ser gerados. Um segundo objetivo foi o de verificar como a presença da condutância iônica ativa no dendrito influencia o comportamento motoneuronal quando o mesmo está sujeito a entradas sinápticas de diferentes tipos. Os novos modelos foram parametrizados baseando-se em dados da literatura experimental para motoneurônios de gatos descerebrados e validados segundo os protocolos experimentais básicos que permitem caracterizar cada tipo de modelo como sendo totalmente ou parcialmente biestável. As entradas sinápticas foram simuladas por processos pontuais de Poisson e os trens de potenciais de ação dos motoneurônios foram analisados. Uma modulação senoidal da intensidade do processo pontual foi usada para estimar as respostas em frequência de cada modelo. Observou-se que, funcionalmente, a presença da condutância iônica dendrítica pode favorecer a ação do motoneurônio durante tarefas posturais, pois, uma vez ativada, a corrente de entrada persistente eleva a excitabilidade motoneuronal tornando os disparos mais regulares, além de prover uma alta sensibilidade dos modelos a entradas sinápticas de baixa frequência, correspondentes às oscilações observadas durante a manutenção da postura ereta quieta. / Mathematical models of motoneurons have been developed as an aid to the understanding of phenomena involving the neuromuscular system, but most of these models have been based on the hypothesis of a passive dendritic tree. This holds for anesthetized animals but not necessarily during normal motor behavior of the intact animal. Experiments with decerebrate animals in which the monoaminergic tracts were maintained intact have shown that more complex behaviors may emerge in motoneurons due to dendritic voltage-gated ionic conductances, which are responsible for a persistent inward current. Therefore, the first aim of this work was to develop computationally-efficient new motoneuron models of different types (i.e. type S, FR and FF) that include a dendritic L-type calcium conductance so that bistability, plateau potential and enhancement of effective synaptic current may be generated. The second aim of this research was to evaluate the effects of the active dendritic ionic conductance on the input-output mapping of presynaptic to postsynaptic spike trains. The new models were parameterized based on data reported in experimental literature on the decerebrate cat preparation, and they were validated using appropriate protocols for either fully or partially bistable dynamics. The synaptic inputs were simulated by Poisson point processes and the output spike trains were analyzed. Sinusoidal modulation of the point process intensity was used for the estimation of each models frequency response. The results suggested that an active dendritic ionic conductance in motoneurons has a functional role during postural tasks, because, when activated, the persistent inward current enhances the motoneuronal excitability, reducing the variability of interspike intervals, and focusing the sensitivity of the models to low frequency inputs that correspond to the low-frequency oscillations that typically occur during quiet standing posture.